SingaporeProduct Registration for Medical Devices in Singapore
Taevas Global guides medical devices manufacturers through the full HSA product registration process in Singapore, reducing time-to-market and eliminating costly compliance missteps. Whether you are entering Singapore for the first time or expanding your
Six Pillars of Singapore Medical Devices Intelligence
Our six interconnected pillars cover every dimension of HSA product registration, from regulatory classification through post-market obligations, giving medical devices companies a complete and actionable market-entry foundation.
Regulatory Classification and Risk Assessment
Singapore's Health Sciences Authority classifies medical devices into four risk classes under the Health Products Act. Correct classification is the single most consequential decision in your registration strategy, determining the submission pathway, evidence requirements, and approval timeline. We conduct a thorough classification analysis against HSA's Medical Device Classification Guidance before any submission work begins.
From Brief to Board-Ready Intelligence
Our four-stage engagement takes your medical device from initial regulatory scoping through a complete, submission-ready dossier and ongoing compliance support, with clear milestones and transparent communication at every step.
Regulatory Scoping and Classification
We begin with a structured intake session to understand your device, its intended use, target patient population, and existing regulatory history in other markets. Using this information we conduct an HSA classification analysis and identify the optimal submission pathway before any dossier work is initiated.
During scoping we review your product technical file, existing certifications such as CE marking or US FDA 510(k) clearance, and any prior HSA correspondence. We deliver a written Regulatory Strategy Memorandum that confirms device class, recommended submission route, estimated HSA processing timeline, and a list of documentation gaps to be addressed in Stage 2.
Singapore Medical Devices Market at a Glance
ASEAN Hub Status
Singapore serves as the regional headquarters for over 30 of the world's top medical technology companies, making it the primary gateway for medical devices market entry into Southeast Asia. HSA registration is widely recognised by ASEAN member states as a credible benchmark for regulatory quality, and several ASEAN countries accept HSA approval as a reference for their own abridged review processes.
HSA Regulatory Rigour
The Health Sciences Authority operates one of Asia's most sophisticated medical devices regulatory frameworks under the Health Products Act and its subsidiary legislation. HSA is a founding member of the International Medical Device Regulators Forum (IMDRF) and actively participates in global regulatory convergence initiatives, meaning its standards are closely aligned with US FDA, CE MDR, and TGA requirements.
High-Value Device Segments
Singapore's medical devices market is dominated by high-value segments including diagnostic imaging, cardiovascular devices, orthopaedic implants, and in-vitro diagnostics, driven by a world-class public hospital network and a growing private healthcare sector. Software as a Medical Device (SaMD) and AI-enabled diagnostics are among the fastest-growing registration categories as HSA develops its digital health regulatory framework.
Manufacturing and Innovation Ecosystem
Singapore hosts a significant medical devices manufacturing base, with companies such as Becton Dickinson, Siemens Healthineers, and Abbott operating major production facilities in the country. The Singapore Economic Development Board actively attracts medical technology investment, and the Agency for Science, Technology and Research (A*STAR) supports device innovation through translational research programmes that create commercial registration opportunities.
Everything in Your Engagement
Every Taevas Global product registration engagement for Singapore delivers a complete set of regulatory outputs, from strategy through submission and post-market compliance, with no hidden scope gaps.
Regulatory Strategy Memorandum
A written document confirming HSA device classification, recommended submission pathway, estimated timeline, and documentation gap list tailored to your specific device and market history.
Complete HSA Submission Dossier
A fully compiled, HSA-ready technical dossier structured to the ASEAN CSDT format, covering all required modules from device description through clinical evidence and quality system documentation.
Gap Analysis and Remediation Report
A prioritised, module-by-module assessment of your existing technical documentation against HSA requirements, with clear remediation actions and responsible party assignments.
Standards Compliance Mapping
A traceability matrix mapping your device documentation to applicable international standards including ISO 13485, ISO 14971, and IEC 62304, with identified conformance gaps and recommended actions.
Local Registrant Facilitation Package
A vetted shortlist of Singapore-based local Registrant candidates, a model Authorised Representative Agreement, and guidance on HSA dealer licence requirements for your distribution model.
HSA Query Response Management
Full management of all HSA requests for additional information during the evaluation period, including drafting, internal review, and timely submission of responses to prevent clock-stops.
Post-Market Surveillance Plan
A documented post-market surveillance plan and adverse event reporting SOP aligned to HSA Medical Device Vigilance requirements, ready for implementation on the first day of commercialisation.
Compliance Calendar and Renewal Schedule
A structured post-approval compliance calendar covering registration renewal dates, variation notification obligations, and periodic safety update reporting timelines for your registered device portfolio.
Built for These Situations
International Manufacturer Entering Singapore
Your device is approved in the US, EU, or Australia and you are ready to enter Singapore as your ASEAN gateway market. You need a regulatory partner who understands HSA's abridged evaluation route and can leverage your existing approvals to accelerate the registration timeline. Without local regulatory expertise, first-time applicants frequently encounter avoidable queries, dossier deficiencies, and delays that push timelines past twelve months.
After Product Registration, Most Clients Move To
Common Questions
Ready to Map Your Singapore Opportunity?
Whether you are preparing your first HSA submission or rescuing a stalled registration, Taevas Global provides the regulatory expertise, local knowledge, and execution discipline to get your medical device registered and commercialised in Singapore. Speak with our team today to scope your engagement.